2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 28488168 | The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC). | 2018 Jan | 1 |
| 2 | 24764583 | PD-L1 expression in triple-negative breast cancer. | 2014 Apr | 4 |